Development of a new therapeutic target with high anti-oncogenic potential in childhood sarcomas: the pharmacological blockade of the Hedgehog co-receptor CDO
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
